Enhancement the sensitivity for the pharmacokinetics of a clinical trial
Description
This project encompasses the pharmacokinetics of a drug being developed to treat an auto-immune orphan disease by drug quantification from patient sera in a clinical trial. Different bioanalytical methods such as mass spectrometry and surface plasmon resonance are evaluated for enhancement of the sensitivity.
Key Data
Projectlead
Project team
Laure-Anne Bickel
Project status
completed, 04/2021 - 12/2022
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT)
Funding partner
Third party